Article

wsj.com on 2021-04-16 12:42

Lilly Seeks to End U.S. Use of Single Covid-19 Antibody Drug Alone

The drugmaker said it will distribute a drug cocktail containing bamlanivimab and a second antibody, etesevimab, that studies indicate together ...

Daniel Skovronsky

Related news

CF.D.A. Clears Monoclonal Antibody Drug From Eli Lilly centralrecorder.com
United States
BEli Lilly Testing a Covid-19 Antibody Drug in Nursing Homes barrons.com
Phase 2 , Phase 1 , Canada
Lilly antibody drug fails in a COVID-19 study; others go on The Day
Canada , Indianapolis
Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use wsj.com
China , Canada
Lilly seeks emergency use of its antibody drug for coronavirus The Toledo Blade
BEli Lilly Has More Positive Data on Its Covid-19 Antibody Therapy barrons.com
Eli Lilly seeks emergency use of its antibody drug for COVID-19 The Day
Indianapolis
Lilly seeks emergency use of its antibody drug for COVID-19 dailyherald.com
Indianapolis
BEli Lilly Will Unveil Alzheimer's Drug Data Next Week. What to Watch.barrons.com
Phase 2
BEli Lilly Makes a Case For Its Alzheimer's Drug as Shares Drop barrons.com
Phase 2
Eli Lilly Asks FDA to Authorize Covid-19 Antibody Drug wsj.com
BEli Lilly Covid Antibody Drug Gets FDA Emergency Clearence bloomberg.com
FDA Approves Eli Lilly Coronavirus Antibody Treatment for Emergency Use breitbart.com
Lilly COVID-19 antibody therapy gets US emergency-use authorization Star Telegram
Brazil , South Africa
MEli Lilly and Amgen to collaborate on COVID-19 antibody therapies marketwatch.com
Phase 2
MLilly initiates Phase 1 clinical trial for a COVID-19 antibody treatment marketwatch.com
Infectious Diseases , Phase 1